Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo
Aim: To formulate proliposomes with a polyphase dispersed system composed of soybean phospholipids, cholesterol, isopropyl myristate and sodium cholate to improve the oral bioavailability of dehydrosilymarin, an oxidized form of herbal drug silymarin. Methods: Dehydrosilymarin was synthesized from a...
Gespeichert in:
Veröffentlicht in: | Acta pharmacologica Sinica 2011-07, Vol.32 (7), p.973-980 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 980 |
---|---|
container_issue | 7 |
container_start_page | 973 |
container_title | Acta pharmacologica Sinica |
container_volume | 32 |
creator | Chu, Chang Tong, Shan-shan Xu, Ying Wang, Li Fu, Min Ge, Yan-ru Yu, Jiang-nan Xu, Xi-ming |
description | Aim: To formulate proliposomes with a polyphase dispersed system composed of soybean phospholipids, cholesterol, isopropyl myristate and sodium cholate to improve the oral bioavailability of dehydrosilymarin, an oxidized form of herbal drug silymarin. Methods: Dehydrosilymarin was synthesized from air oxidation of silymarin in the presence of pyridine, and proliposomes were prepared by a film dispersion-freeze drying method. Morphological characterization of proliposomes was observed using a transmission electron microscope. Particle size and encapsulation efficiency of proliposomes were measured. The in vitro release of dehydrosilymatin from suspension and proliposomes was evaluated. The oral bioavailability of dehydrosilymarin suspension and proliposomes was investigated in rabbits. Results: The proliposomes prepared under the optimum conditions were spherical and smooth with a mean particle size in the range of 7 to 50 nm. Encapsulation efficiency was 81.59%±0.24%. The in vitro accumulative release percent of dehydrosilymarinloaded proliposomes was stable, which was slow in pH 1.2, and increased continuously in pH 6.8, and finally reached 86.41% at 12 h. After oral administration in rabbits, the relative bioavailability of proliposomes versus suspension in rabbits was 228.85%. Conclusion: Proliposomes may be a useful vehicle for oral delivery of dehydrosilymarin, a drug poorly soluble in water. |
doi_str_mv | 10.1038/aps.2011.25 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4003120</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>38696064</cqvip_id><sourcerecordid>2403841951</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-895bb8d3aa3c1035c1b5cff052e4a2e5af16991b1a55478110d176c4968c53853</originalsourceid><addsrcrecordid>eNptUctO3DAUtRAIKLBij0K3JYOvX3E2SAi1BQmpLGBtOYkzY5Sxg52JNL_Sb-k_9RfqYYYBpK58H8fnnnsPQqeAJ4CpvNR9nBAMMCF8Bx1CwXheEM52UywKyBmW9AB9ifEZY0oolPvogIAQosD0EJmH4Dvb--jnJmatD5kPussa09nRhGXm2xTPlk3w0XbLuQ7W_f3zO-uD6XXQg_Uu067JzKi7xTq1LhvtEPxr_TUZ_THaa3UXzcnmPUJPP74_3tzm979-3t1c3-c1K_CQy5JXlWyo1rROq_EaKl63LebEME0M1y2IsoQKNOeskAC4gULUrBSy5lRyeoSu1rz9opqbpjZuSNuoPtikfKm8tupzx9mZmvpRsXQbIDgRfN0QBP-yMHFQz34RXNKsZCE54QSvQN_WoDpdJQbTbgcAVitLVLJErSxRZKXp7KOmLfbNgwS4WANiarmpCe8z_893vpk-8276kn5sKakUpcCC0X98UqR5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>878525200</pqid></control><display><type>article</type><title>Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Chu, Chang ; Tong, Shan-shan ; Xu, Ying ; Wang, Li ; Fu, Min ; Ge, Yan-ru ; Yu, Jiang-nan ; Xu, Xi-ming</creator><creatorcontrib>Chu, Chang ; Tong, Shan-shan ; Xu, Ying ; Wang, Li ; Fu, Min ; Ge, Yan-ru ; Yu, Jiang-nan ; Xu, Xi-ming</creatorcontrib><description>Aim: To formulate proliposomes with a polyphase dispersed system composed of soybean phospholipids, cholesterol, isopropyl myristate and sodium cholate to improve the oral bioavailability of dehydrosilymarin, an oxidized form of herbal drug silymarin. Methods: Dehydrosilymarin was synthesized from air oxidation of silymarin in the presence of pyridine, and proliposomes were prepared by a film dispersion-freeze drying method. Morphological characterization of proliposomes was observed using a transmission electron microscope. Particle size and encapsulation efficiency of proliposomes were measured. The in vitro release of dehydrosilymatin from suspension and proliposomes was evaluated. The oral bioavailability of dehydrosilymarin suspension and proliposomes was investigated in rabbits. Results: The proliposomes prepared under the optimum conditions were spherical and smooth with a mean particle size in the range of 7 to 50 nm. Encapsulation efficiency was 81.59%±0.24%. The in vitro accumulative release percent of dehydrosilymarinloaded proliposomes was stable, which was slow in pH 1.2, and increased continuously in pH 6.8, and finally reached 86.41% at 12 h. After oral administration in rabbits, the relative bioavailability of proliposomes versus suspension in rabbits was 228.85%. Conclusion: Proliposomes may be a useful vehicle for oral delivery of dehydrosilymarin, a drug poorly soluble in water.</description><identifier>ISSN: 1671-4083</identifier><identifier>EISSN: 1745-7254</identifier><identifier>DOI: 10.1038/aps.2011.25</identifier><identifier>PMID: 21666703</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Administration, Oral ; Animals ; Biological Availability ; Biomedical and Life Sciences ; Biomedicine ; Immunology ; Internal Medicine ; Liposomes - chemistry ; Liposomes - ultrastructure ; Medical Microbiology ; Original ; original-article ; Pharmacology/Toxicology ; Protective Agents - administration & dosage ; Protective Agents - chemical synthesis ; Protective Agents - pharmacokinetics ; Rabbits ; Silybum marianum - chemistry ; Silymarin - administration & dosage ; Silymarin - analogs & derivatives ; Silymarin - chemical synthesis ; Silymarin - pharmacokinetics ; Vaccine ; 体内 ; 体外释放 ; 口服给药 ; 水飞蓟素 ; 生物利用度 ; 电子显微镜观察 ; 肉豆蔻酸异丙酯 ; 评价</subject><ispartof>Acta pharmacologica Sinica, 2011-07, Vol.32 (7), p.973-980</ispartof><rights>CPS and SIMM 2011</rights><rights>Copyright Nature Publishing Group Jul 2011</rights><rights>Copyright © 2011 CPS and SIMM 2011 CPS and SIMM</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-895bb8d3aa3c1035c1b5cff052e4a2e5af16991b1a55478110d176c4968c53853</citedby><cites>FETCH-LOGICAL-c470t-895bb8d3aa3c1035c1b5cff052e4a2e5af16991b1a55478110d176c4968c53853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/95561A/95561A.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003120/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003120/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21666703$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chu, Chang</creatorcontrib><creatorcontrib>Tong, Shan-shan</creatorcontrib><creatorcontrib>Xu, Ying</creatorcontrib><creatorcontrib>Wang, Li</creatorcontrib><creatorcontrib>Fu, Min</creatorcontrib><creatorcontrib>Ge, Yan-ru</creatorcontrib><creatorcontrib>Yu, Jiang-nan</creatorcontrib><creatorcontrib>Xu, Xi-ming</creatorcontrib><title>Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo</title><title>Acta pharmacologica Sinica</title><addtitle>Acta Pharmacol Sin</addtitle><addtitle>Acta Pharmacologica Sinica</addtitle><description>Aim: To formulate proliposomes with a polyphase dispersed system composed of soybean phospholipids, cholesterol, isopropyl myristate and sodium cholate to improve the oral bioavailability of dehydrosilymarin, an oxidized form of herbal drug silymarin. Methods: Dehydrosilymarin was synthesized from air oxidation of silymarin in the presence of pyridine, and proliposomes were prepared by a film dispersion-freeze drying method. Morphological characterization of proliposomes was observed using a transmission electron microscope. Particle size and encapsulation efficiency of proliposomes were measured. The in vitro release of dehydrosilymatin from suspension and proliposomes was evaluated. The oral bioavailability of dehydrosilymarin suspension and proliposomes was investigated in rabbits. Results: The proliposomes prepared under the optimum conditions were spherical and smooth with a mean particle size in the range of 7 to 50 nm. Encapsulation efficiency was 81.59%±0.24%. The in vitro accumulative release percent of dehydrosilymarinloaded proliposomes was stable, which was slow in pH 1.2, and increased continuously in pH 6.8, and finally reached 86.41% at 12 h. After oral administration in rabbits, the relative bioavailability of proliposomes versus suspension in rabbits was 228.85%. Conclusion: Proliposomes may be a useful vehicle for oral delivery of dehydrosilymarin, a drug poorly soluble in water.</description><subject>Administration, Oral</subject><subject>Animals</subject><subject>Biological Availability</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Immunology</subject><subject>Internal Medicine</subject><subject>Liposomes - chemistry</subject><subject>Liposomes - ultrastructure</subject><subject>Medical Microbiology</subject><subject>Original</subject><subject>original-article</subject><subject>Pharmacology/Toxicology</subject><subject>Protective Agents - administration & dosage</subject><subject>Protective Agents - chemical synthesis</subject><subject>Protective Agents - pharmacokinetics</subject><subject>Rabbits</subject><subject>Silybum marianum - chemistry</subject><subject>Silymarin - administration & dosage</subject><subject>Silymarin - analogs & derivatives</subject><subject>Silymarin - chemical synthesis</subject><subject>Silymarin - pharmacokinetics</subject><subject>Vaccine</subject><subject>体内</subject><subject>体外释放</subject><subject>口服给药</subject><subject>水飞蓟素</subject><subject>生物利用度</subject><subject>电子显微镜观察</subject><subject>肉豆蔻酸异丙酯</subject><subject>评价</subject><issn>1671-4083</issn><issn>1745-7254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptUctO3DAUtRAIKLBij0K3JYOvX3E2SAi1BQmpLGBtOYkzY5Sxg52JNL_Sb-k_9RfqYYYBpK58H8fnnnsPQqeAJ4CpvNR9nBAMMCF8Bx1CwXheEM52UywKyBmW9AB9ifEZY0oolPvogIAQosD0EJmH4Dvb--jnJmatD5kPussa09nRhGXm2xTPlk3w0XbLuQ7W_f3zO-uD6XXQg_Uu067JzKi7xTq1LhvtEPxr_TUZ_THaa3UXzcnmPUJPP74_3tzm979-3t1c3-c1K_CQy5JXlWyo1rROq_EaKl63LebEME0M1y2IsoQKNOeskAC4gULUrBSy5lRyeoSu1rz9opqbpjZuSNuoPtikfKm8tupzx9mZmvpRsXQbIDgRfN0QBP-yMHFQz34RXNKsZCE54QSvQN_WoDpdJQbTbgcAVitLVLJErSxRZKXp7KOmLfbNgwS4WANiarmpCe8z_893vpk-8276kn5sKakUpcCC0X98UqR5</recordid><startdate>20110701</startdate><enddate>20110701</enddate><creator>Chu, Chang</creator><creator>Tong, Shan-shan</creator><creator>Xu, Ying</creator><creator>Wang, Li</creator><creator>Fu, Min</creator><creator>Ge, Yan-ru</creator><creator>Yu, Jiang-nan</creator><creator>Xu, Xi-ming</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20110701</creationdate><title>Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo</title><author>Chu, Chang ; Tong, Shan-shan ; Xu, Ying ; Wang, Li ; Fu, Min ; Ge, Yan-ru ; Yu, Jiang-nan ; Xu, Xi-ming</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-895bb8d3aa3c1035c1b5cff052e4a2e5af16991b1a55478110d176c4968c53853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Administration, Oral</topic><topic>Animals</topic><topic>Biological Availability</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Immunology</topic><topic>Internal Medicine</topic><topic>Liposomes - chemistry</topic><topic>Liposomes - ultrastructure</topic><topic>Medical Microbiology</topic><topic>Original</topic><topic>original-article</topic><topic>Pharmacology/Toxicology</topic><topic>Protective Agents - administration & dosage</topic><topic>Protective Agents - chemical synthesis</topic><topic>Protective Agents - pharmacokinetics</topic><topic>Rabbits</topic><topic>Silybum marianum - chemistry</topic><topic>Silymarin - administration & dosage</topic><topic>Silymarin - analogs & derivatives</topic><topic>Silymarin - chemical synthesis</topic><topic>Silymarin - pharmacokinetics</topic><topic>Vaccine</topic><topic>体内</topic><topic>体外释放</topic><topic>口服给药</topic><topic>水飞蓟素</topic><topic>生物利用度</topic><topic>电子显微镜观察</topic><topic>肉豆蔻酸异丙酯</topic><topic>评价</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chu, Chang</creatorcontrib><creatorcontrib>Tong, Shan-shan</creatorcontrib><creatorcontrib>Xu, Ying</creatorcontrib><creatorcontrib>Wang, Li</creatorcontrib><creatorcontrib>Fu, Min</creatorcontrib><creatorcontrib>Ge, Yan-ru</creatorcontrib><creatorcontrib>Yu, Jiang-nan</creatorcontrib><creatorcontrib>Xu, Xi-ming</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta pharmacologica Sinica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chu, Chang</au><au>Tong, Shan-shan</au><au>Xu, Ying</au><au>Wang, Li</au><au>Fu, Min</au><au>Ge, Yan-ru</au><au>Yu, Jiang-nan</au><au>Xu, Xi-ming</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo</atitle><jtitle>Acta pharmacologica Sinica</jtitle><stitle>Acta Pharmacol Sin</stitle><addtitle>Acta Pharmacologica Sinica</addtitle><date>2011-07-01</date><risdate>2011</risdate><volume>32</volume><issue>7</issue><spage>973</spage><epage>980</epage><pages>973-980</pages><issn>1671-4083</issn><eissn>1745-7254</eissn><abstract>Aim: To formulate proliposomes with a polyphase dispersed system composed of soybean phospholipids, cholesterol, isopropyl myristate and sodium cholate to improve the oral bioavailability of dehydrosilymarin, an oxidized form of herbal drug silymarin. Methods: Dehydrosilymarin was synthesized from air oxidation of silymarin in the presence of pyridine, and proliposomes were prepared by a film dispersion-freeze drying method. Morphological characterization of proliposomes was observed using a transmission electron microscope. Particle size and encapsulation efficiency of proliposomes were measured. The in vitro release of dehydrosilymatin from suspension and proliposomes was evaluated. The oral bioavailability of dehydrosilymarin suspension and proliposomes was investigated in rabbits. Results: The proliposomes prepared under the optimum conditions were spherical and smooth with a mean particle size in the range of 7 to 50 nm. Encapsulation efficiency was 81.59%±0.24%. The in vitro accumulative release percent of dehydrosilymarinloaded proliposomes was stable, which was slow in pH 1.2, and increased continuously in pH 6.8, and finally reached 86.41% at 12 h. After oral administration in rabbits, the relative bioavailability of proliposomes versus suspension in rabbits was 228.85%. Conclusion: Proliposomes may be a useful vehicle for oral delivery of dehydrosilymarin, a drug poorly soluble in water.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>21666703</pmid><doi>10.1038/aps.2011.25</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1671-4083 |
ispartof | Acta pharmacologica Sinica, 2011-07, Vol.32 (7), p.973-980 |
issn | 1671-4083 1745-7254 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4003120 |
source | MEDLINE; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry |
subjects | Administration, Oral Animals Biological Availability Biomedical and Life Sciences Biomedicine Immunology Internal Medicine Liposomes - chemistry Liposomes - ultrastructure Medical Microbiology Original original-article Pharmacology/Toxicology Protective Agents - administration & dosage Protective Agents - chemical synthesis Protective Agents - pharmacokinetics Rabbits Silybum marianum - chemistry Silymarin - administration & dosage Silymarin - analogs & derivatives Silymarin - chemical synthesis Silymarin - pharmacokinetics Vaccine 体内 体外释放 口服给药 水飞蓟素 生物利用度 电子显微镜观察 肉豆蔻酸异丙酯 评价 |
title | Proliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivo |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T23%3A15%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Proliposomes%20for%20oral%20delivery%20of%20dehydrosilymarin%EF%BC%9A%20preparation%20and%20evaluation%20in%20vitro%20and%20in%20vivo&rft.jtitle=Acta%20pharmacologica%20Sinica&rft.au=Chu,%20Chang&rft.date=2011-07-01&rft.volume=32&rft.issue=7&rft.spage=973&rft.epage=980&rft.pages=973-980&rft.issn=1671-4083&rft.eissn=1745-7254&rft_id=info:doi/10.1038/aps.2011.25&rft_dat=%3Cproquest_pubme%3E2403841951%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=878525200&rft_id=info:pmid/21666703&rft_cqvip_id=38696064&rfr_iscdi=true |